Trials / Withdrawn
WithdrawnNCT02812849
Somatostatin Receptor Imaging in Cardiac Sarcoidosis
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the trial is to determine the accuracy of Cu-64 labelled DOTATATE for diagnosing cardiac sarcoidosis using PET/CT or PET/MRI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cu-64 DOTATATE |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2019-11-01
- Completion
- 2020-02-27
- First posted
- 2016-06-24
- Last updated
- 2020-10-14
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02812849. Inclusion in this directory is not an endorsement.